Cargando…

Implementation of the Treat-to-Target Concept in Evaluation of Psoriatic Arthritis Patients

Background: The treat-to-target approach was recently adopted for psoriatic arthritis (PsA) management. Objective: To assess the implementation of the “treat-to-target” (T2T) concept in daily management of PsA by use of composite scores of disease activity versus clinical judgement alone. Methods: A...

Descripción completa

Detalles Bibliográficos
Autores principales: Gazitt, Tal, Elhija, Muhanad Abu, Haddad, Amir, Lavi, Idit, Elias, Muna, Zisman, Devy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658564/
https://www.ncbi.nlm.nih.gov/pubmed/34884369
http://dx.doi.org/10.3390/jcm10235659
_version_ 1784612759838654464
author Gazitt, Tal
Elhija, Muhanad Abu
Haddad, Amir
Lavi, Idit
Elias, Muna
Zisman, Devy
author_facet Gazitt, Tal
Elhija, Muhanad Abu
Haddad, Amir
Lavi, Idit
Elias, Muna
Zisman, Devy
author_sort Gazitt, Tal
collection PubMed
description Background: The treat-to-target approach was recently adopted for psoriatic arthritis (PsA) management. Objective: To assess the implementation of the “treat-to-target” (T2T) concept in daily management of PsA by use of composite scores of disease activity versus clinical judgement alone. Methods: A total of 117 PsA patients from a longitudinal PsA cohort were enrolled consecutively in the study during each patient’s first clinic visit during 2016–2017. Clinic notes from the treating rheumatologist were reviewed by an independent rheumatologist, noting clinical impression of disease activity, treatment changes based on clinical judgement, and rationale. Treatment changes were then compared to the use of formal disease activity parameters in Minimal Disease Activity (MDA) and Disease Activity Index for Psoriatic Arthritis (DAPSA) composite measures. All associations were assessed using the chi-square test or the Mann–Whitney test, as appropriate. Results: The 117 PsA patient cohort consisted of 65.5% women, mean age 58.4 ± 13.6 years. Clinical judgement of treating rheumatologist concorded with MDA and DAPSA in 76 (65.5%) and 74 (64.9%) patients, respectively. Agreement between clinical judgement and composite measure criteria did not correlate with patient age, sex, alcohol/tobacco use, or treatment regimens chosen. Disagreement between physician assessment and MDA occurred in 40 (34.5%) cases: in 30 cases, the MDA status was overestimated due to disregard of patient reported outcomes (PRO), while underestimation of MDA status occurred in 25% of cases with treatment changes made in patients with a single active joint or enthesis. Underestimation of disease activity using DAPSA occurred in 22 cases and could be attributed to disregarding tender joint count, patient pain visual analogue scale and C-reactive protein level. Conclusion: In our cohort, agreement between clinical impression and formal composite measure utilization for implementation of T2T strategy occurred in 65% of patients. Discordance resulted from physicians’ overlooking PRO and emphasizing objective findings when using clinical judgement alone.
format Online
Article
Text
id pubmed-8658564
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86585642021-12-10 Implementation of the Treat-to-Target Concept in Evaluation of Psoriatic Arthritis Patients Gazitt, Tal Elhija, Muhanad Abu Haddad, Amir Lavi, Idit Elias, Muna Zisman, Devy J Clin Med Article Background: The treat-to-target approach was recently adopted for psoriatic arthritis (PsA) management. Objective: To assess the implementation of the “treat-to-target” (T2T) concept in daily management of PsA by use of composite scores of disease activity versus clinical judgement alone. Methods: A total of 117 PsA patients from a longitudinal PsA cohort were enrolled consecutively in the study during each patient’s first clinic visit during 2016–2017. Clinic notes from the treating rheumatologist were reviewed by an independent rheumatologist, noting clinical impression of disease activity, treatment changes based on clinical judgement, and rationale. Treatment changes were then compared to the use of formal disease activity parameters in Minimal Disease Activity (MDA) and Disease Activity Index for Psoriatic Arthritis (DAPSA) composite measures. All associations were assessed using the chi-square test or the Mann–Whitney test, as appropriate. Results: The 117 PsA patient cohort consisted of 65.5% women, mean age 58.4 ± 13.6 years. Clinical judgement of treating rheumatologist concorded with MDA and DAPSA in 76 (65.5%) and 74 (64.9%) patients, respectively. Agreement between clinical judgement and composite measure criteria did not correlate with patient age, sex, alcohol/tobacco use, or treatment regimens chosen. Disagreement between physician assessment and MDA occurred in 40 (34.5%) cases: in 30 cases, the MDA status was overestimated due to disregard of patient reported outcomes (PRO), while underestimation of MDA status occurred in 25% of cases with treatment changes made in patients with a single active joint or enthesis. Underestimation of disease activity using DAPSA occurred in 22 cases and could be attributed to disregarding tender joint count, patient pain visual analogue scale and C-reactive protein level. Conclusion: In our cohort, agreement between clinical impression and formal composite measure utilization for implementation of T2T strategy occurred in 65% of patients. Discordance resulted from physicians’ overlooking PRO and emphasizing objective findings when using clinical judgement alone. MDPI 2021-11-30 /pmc/articles/PMC8658564/ /pubmed/34884369 http://dx.doi.org/10.3390/jcm10235659 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Gazitt, Tal
Elhija, Muhanad Abu
Haddad, Amir
Lavi, Idit
Elias, Muna
Zisman, Devy
Implementation of the Treat-to-Target Concept in Evaluation of Psoriatic Arthritis Patients
title Implementation of the Treat-to-Target Concept in Evaluation of Psoriatic Arthritis Patients
title_full Implementation of the Treat-to-Target Concept in Evaluation of Psoriatic Arthritis Patients
title_fullStr Implementation of the Treat-to-Target Concept in Evaluation of Psoriatic Arthritis Patients
title_full_unstemmed Implementation of the Treat-to-Target Concept in Evaluation of Psoriatic Arthritis Patients
title_short Implementation of the Treat-to-Target Concept in Evaluation of Psoriatic Arthritis Patients
title_sort implementation of the treat-to-target concept in evaluation of psoriatic arthritis patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658564/
https://www.ncbi.nlm.nih.gov/pubmed/34884369
http://dx.doi.org/10.3390/jcm10235659
work_keys_str_mv AT gazitttal implementationofthetreattotargetconceptinevaluationofpsoriaticarthritispatients
AT elhijamuhanadabu implementationofthetreattotargetconceptinevaluationofpsoriaticarthritispatients
AT haddadamir implementationofthetreattotargetconceptinevaluationofpsoriaticarthritispatients
AT laviidit implementationofthetreattotargetconceptinevaluationofpsoriaticarthritispatients
AT eliasmuna implementationofthetreattotargetconceptinevaluationofpsoriaticarthritispatients
AT zismandevy implementationofthetreattotargetconceptinevaluationofpsoriaticarthritispatients